Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zavegepant PK Study in Healthy Lactating Women
NCT06453356Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jun 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of zavegepant in migraine, sponsored by Pfizer. Primary endpoints: Area Under the Breast Milk Concentration-time Profile from time 0 extrapolated to infinite time, Area Under the Breast Milk Concentration-time Profile From Time Zero to the Time of Last Quantifiable Concentration and 4 more. Started Jun 2024; status: completed.
02
Drugs
zavegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06453356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06453356.